Update with Pressure BioSciences, Inc. - Discusses Market Opportunity, Differentiating Factors and New Patents

Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market, according to the Company’s website (www.PressureBioSciences.com). SNNLive caught up with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. at the at the 2017 Disruptive Growth Company Showcase in New York City, NY.

In this SNNLive Video Interview, Mr. Schumacher and our host discuss the following topics:

- Overview of Pressure BioSciences, Inc.

- Update since our last interview (click here)

- The company’s patented Pressure Cycling Technology (“PCT”) Platform

- Key Opinion and other Laboratories where you can find the company’s equipment

- What differentiates the company’s equipment from that of its competitors

- Expansion of its sales force

- Receipt of initial patents on its Ultra Shear Technology (“UST”)

For more information about Pressure BioSciences, Inc., please visit: www.PressureBiosciences.com

The interview may contain forward-looking statements about Pressure BioSciences, Inc. See Pressure BioSciences’ periodic filings with the Securities and Exchange Commission for more complete information.